Key stats
About NIPPONAMC - NETFPHARMA
Expense ratio
0.19%
Home page
Inception date
Jul 2, 2021
ISIN
INF204KC1089
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errs. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history